The effectiveness of Mexidol® for cognitive disorders: decrease in memory, attention, performance

Time codes:
  • 00:00

    The main symptom of chronic brain ischemia

  • 00:45

    Mini-Cog test methodology to check cognitive function

Zakharov Vladimir Vladimirovich - MD, professor at the Department of Nervous Diseases Faculty of Faculty of Medicine the First MGMU named after THEM. Sechenov

Announcement:

At the moment, it is proved that the main symptom of chronic brain ischemia is cognitive disorders. This symptom is the main one for both the doctor and the patient. For the patient, because it is cognitive disorders that worsen the quality of life, but for the doctor, because this is the main guideline in the diagnosis. As pathogenetic therapy, Mexidol® is often recommended. Mexidol® has an anti -amnestic effect for memory and attention and has a pronounced ability to improve the processes of higher nervous activity. The effectiveness of the drug with brain ischemia, cognitive disorders, anxiety disorders, etc. has been proved.

Block of articles on this topic

Cognitive disorders diagnostic algorithm in outpatient practice

Authors:
E.A. Mkhitaryan, M.A. ATTIC

Arterial hypertension and cognitive disorders. The gaze of a neurologist

Author:
A.I. Fedin

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. Bogolepova 1, 2

1 FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
2 FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. Ostroumova, A.I. Kochetkov, N.A. Shatalova

Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. Zakharov 1 , A.I. Fedin 2 , E.A. Mkhitaryan 2, 3

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com